Barnes A G, Barnfield C, Brew R, Klavinskis L S
Department of Immunobiology, Guy's, King's and St Thomas' Medical School (GKT), St Thomas Street, London SE1 9RT, UK.
Curr Opin Mol Ther. 2000 Feb;2(1):87-93.
The development of DNA vaccination to mucosal surfaces has continued apace over the last 2 years, with the investigation of several novel delivery vehicles. There have been advances in the understanding of the basic immunological mechanisms behind the induction of immune responses by plasmid DNA. The mechanistic insights are paving the way for the design of a second generation of mucosally delivered DNA vaccines. This article reviews the recent progress in the field of microparticle, cationic lipid and bacterial delivery systems. All these mechanisms afford some protection from environmental degradation and facilitate DNA uptake. These methods have been compared with respect to transfection efficiency, ability to elicit a full range of immune responses and their relative safety for in vivo applications.
在过去两年中,DNA疫苗向黏膜表面递送的研发进展迅速,有多种新型递送载体得到研究。在对质粒DNA诱导免疫反应背后的基本免疫机制的理解方面取得了进展。这些机制性见解为设计第二代黏膜递送DNA疫苗铺平了道路。本文综述了微粒、阳离子脂质和细菌递送系统领域的最新进展。所有这些机制都能在一定程度上保护DNA免受环境降解并促进其摄取。已对这些方法在转染效率、引发全方位免疫反应的能力及其体内应用的相对安全性方面进行了比较。